Psychedelic Research for Mass Mental Health
At MAPS, we’ve been dedicated to psychedelic research since 1986. Now, we’re shifting perceptions to give medicine and our society the tools needed to heal—no matter who you are.
Help Us Deliver Global Healing
Together, we can bring real change to mental health and help millions feel well again. Your tax-deductible contribution supports psychedelic research, drug policy reform, public education, health equity and harm reduction initiatives, and our general operations.
Thanks for your contribution to MAPS!
Your tax-deductible contribution supports psychedelic science research, drug policy reform, public education, harm reduction, peer support, and our general operations.
Join us for Psychedelic Science 2023, the largest psychedelic gathering in history, from
June 17-25, 2023, in Denver, Colorado.
Our Research Collaborators
Thanks to the innovative and passionate thinkers across the country, MAPS has been able to uncover even more about the potential for psychedelic healing for mass mental health.
Choose Your Journey
Whether you’re looking to heal or be healed, make a one-time or recurring donation, here are some ways you can help us takes steps towards showing the world the positive benefits of psychedelic science.
The Latest Science. Research Updates. Event Announcements.
Featured Media
The New York Times: Dr. Bronner’s, the Soap Company, Dips Into Psychedelics
Forbes: Exclusive: MAPS Accepts $500,000 Donation From Atai Life Sciences’ Philanthropy Arm
CBS News: Using Psychedelics to Treat Veterans’ PTSD
The New York Times: Veterans Have Become Unlikely Lobbyists in Push to Legalize Psychedelic Drugs
Matters Arising: MAPS’ Pivotal Phase 3 Trial Advances Scientific Discourse in Nature Medicine
Fox 7 Austin: Research on Psychedelic Mushrooms, Ecstasy as PTSD Treatment Shows Positive Results
Life Science Leader: MAPS: Walking The Talk On Intellectual Property?
Forbes: GoDaddy Billionaire Bob Parsons Believes Psychedelics Can Heal Trauma—And He’s Putting His Money (And Brain) On The Line
Newsy: More Doctors Are Embracing Psychedelics
The Fly: Rising High – Exclusive Talk with Psychedelics Organization MAPS PBC
NEO.LIFE: Do Psychedelics Need Psychiatrists?
Harper’s BAZAAR: Mommies Who Mushroom
In 2014, after years of positive growth, we launched MAPS Public Benefit Corporation (MAPS PBC)—our sister in psychedelic research. The goal of MAPS PBC is to catalyze healing and well-being through psychedelic drug development, therapist training programs, and, ultimately, the sales of prescription psychedelics. MAPS PBC, a wholly owned subsidiary of MAPS, prioritizes patients over profit and is driven by core values that promote sustainability, accountability, transparency, and equitable access to care.
Your Crash Course in Psychedelics
Hear our founder, Rick Doblin, Ph.D., discuss the history and the future of psychedelics.
We Stand Firm in Our Roots
Since 1986, MAPS has been guided by the same aspirational beacons that, to this day, continue to inform our path forward. By integrating the past and embodying our shared values in the present, we are actively co-creating a future that honors every individual’s right to heal. Our decades-long history of perseverance in the face of fear-based stigma reveals our radical commitment to pursuing our vision with balance, accountability, and integrity.
Explore our research
We’ve come a long way from the counterculture movement of the 1960’s—and, thanks to decades of studies, so has our data. We now understand more about the healing powers of psychedelics than ever before, and we’re excited to share our findings with you and the world.